Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Mar 2010 07:00 AM
RNS
Sales and Distribution Agreem
15 Mar 2010 11:07 AM
RNS
ValiRx announces good stabili
09 Mar 2010 07:00 AM
RNS
Funding and Partnership Agree
05 Mar 2010 03:00 PM
RNS
Issue of Equity
26 Feb 2010 04:30 PM
RNS
Total Voting Rights
16 Feb 2010 09:00 AM
RNS
Issue of Equity
29 Jan 2010 10:10 AM
RNS
Total Voting Rights
19 Jan 2010 07:00 AM
RNS
GeneICE Update
13 Jan 2010 07:56 AM
RNS
Issue of Equity
31 Dec 2009 08:03 AM
RNS
Issue of Equity
30 Dec 2009 01:57 PM
RNS
Result of General Meeting
22 Dec 2009 12:19 PM
RNS
Regional Funding
11 Dec 2009 07:42 AM
RNS
£3m Equity Purchase Agreemen
04 Dec 2009 10:14 AM
RNS
Notice of General Meeting
25 Nov 2009 07:00 AM
RNS
Trading Update
28 Sep 2009 07:40 AM
RNS
Half Yearly Report
14 Sep 2009 07:00 AM
RNS
New Distribution Venture & Tr
29 Jul 2009 08:06 AM
RNS
Australian Patent Acceptance
03 Jul 2009 10:57 AM
RNS
Result of AGM
10 Jun 2009 01:35 PM
RNS
Final Results
10 Jun 2009 08:50 AM
RNS
Award for cancer therapeutics
29 May 2009 07:00 AM
RNS
Placing Summary and Total Vot
11 May 2009 07:00 AM
RNS
Issue of Equity
05 May 2009 01:00 PM
RNS
Issue of Equity
30 Apr 2009 07:00 AM
RNS
Total Voting Rights
27 Apr 2009 07:00 AM
RNS
Issue of Equity
16 Apr 2009 03:05 PM
RNS
Holding(s) in Company
16 Apr 2009 07:00 AM
RNS
Issue of Equity
09 Apr 2009 07:00 AM
RNS
Issue of Equity
06 Apr 2009 09:59 AM
RNS
Holding(s) in Company
31 Mar 2009 07:00 AM
RNS
Update to the Sale of Shares
31 Mar 2009 07:00 AM
RNS
Issue of Equity and Directors
12 Mar 2009 07:00 AM
RNS
ValiRx Announces Promising In
27 Feb 2009 07:00 AM
RNS
Total Voting Rights
13 Feb 2009 10:52 AM
RNS
Result of EGM
30 Jan 2009 07:00 AM
RNS
Total Voting Rights
29 Jan 2009 12:07 PM
RNS
Availability of circular
28 Jan 2009 11:55 AM
RNS
Proposed Reorganisation and G
05 Jan 2009 02:50 PM
RNS
Issue of Equity
31 Dec 2008 09:00 AM
RNS
Total Voting Rights
15 Dec 2008 07:00 AM
RNS
Global Distribution Agreement
05 Dec 2008 02:00 PM
RNS
Change of Adviser
27 Nov 2008 04:19 PM
RNS
Issue of Equity
16 Sep 2008 07:00 AM
RNS
Update on cancer detection te
11 Sep 2008 07:00 AM
RNS
Interim Results
10 Sep 2008 10:33 AM
RNS
Notice of Results
18 Aug 2008 04:02 PM
RNS
Appointment of director
31 Jul 2008 07:00 AM
RNS
Total Voting Rights
28 Jul 2008 02:48 PM
RNS
AGM Statement
23 Jul 2008 04:02 PM
RNS
Director's Dealing

ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)

ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.

As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.

The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.

In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.

UK 100

Latest directors dealings